1. Home
  2. PRMB vs ICLR Comparison

PRMB vs ICLR Comparison

Compare PRMB & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Primo Brands Corporation

PRMB

Primo Brands Corporation

HOLD

Current Price

$22.70

Market Cap

8.8B

Sector

N/A

ML Signal

HOLD

Logo ICON plc

ICLR

ICON plc

HOLD

Current Price

$165.76

Market Cap

9.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRMB
ICLR
Founded
1955
1990
Country
United States
Ireland
Employees
12000
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
9.3B
IPO Year
N/A
2001

Fundamental Metrics

Financial Performance
Metric
PRMB
ICLR
Price
$22.70
$165.76
Analyst Decision
Buy
Buy
Analyst Count
9
13
Target Price
$24.00
$178.62
AVG Volume (30 Days)
2.7M
785.7K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
2.49%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.34
N/A
Revenue Next Year
$3.56
N/A
P/E Ratio
N/A
$12.91
Revenue Growth
N/A
N/A
52 Week Low
$14.36
$66.57
52 Week High
$29.00
$203.91

Technical Indicators

Market Signals
Indicator
PRMB
ICLR
Relative Strength Index (RSI) 38.60 57.24
Support Level $21.74 $162.06
Resistance Level $22.96 $191.33
Average True Range (ATR) 0.75 5.88
MACD -0.25 -1.50
Stochastic Oscillator 5.21 25.97

Price Performance

Historical Comparison
PRMB
ICLR

About PRMB Primo Brands Corporation

Primo Brands Corp is a North American branded beverage company focused on healthy hydration. It delivers sustainably and domestically sourced diversified offerings across products, formats, channels, price points, and consumer occasions, distributed in every state and Canada. Primo Brands is in reusable packaging, helping to reduce waste through its reusable, multi-serve bottles and brand packaging portfolio, which includes recycled plastic, aluminum, and glass.

About ICLR ICON plc

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

Share on Social Networks: